Pennsylvania HB 2020: An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose response immunity.

Status: Referred to Judiciary (as of 2024-02-07)

State: Pennsylvania · Session: 2023-2024 · Bill: HB 2020

Sponsors: Frank Burns, Christina Sappey, G. Roni Green, Johanny Cepeda-Freytiz, Jose Giral

View Pennsylvania HB 2020 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.